News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Bartomeu Massuti on Optó-TROP 01 Lung study at ASCO24
Photo taken from Bartomeu Massuti/X
Jun 1, 2024, 21:13

Bartomeu Massuti on Optó-TROP 01 Lung study at ASCO24

Bartomeu Massuti, Associate Professor at Miguel Hernandez University of Elche, shared a post on X:

“Optó-TROP 01 Lung study: Sacitumumab-Tirumoten plus Immunity-Checkpoint-Inhibitor approach in pretreated NSCLC at ASCO24: interesting results but development continues with Pembrolizumab.”

Bartomeu Massuti

Source: Bartomeu Massuti/X

ASCO24 Bartomeu Massuti cancer NSCLC OncoDaily Oncology pembrolizumab
Special Coverage
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene
Blog
Mar 31, 2025, 18:21
Cecilia Pompili: PROs research from ELCC25 on NSCLC treatment and thoracic surgery
Blog
Mar 31, 2025, 18:15
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Blog
Mar 31, 2025, 18:09
Ray Chan: Can’t wait for William Dale’s lecture this Thursday at Flinders University
Science
Mar 31, 2025, 18:00
Partha Basu: Guidance from IARC/WHO on validating HPV detection tests with lower valency